Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

April Armstrong,Alvaro González-Cantero,Saakshi Khattri, Guilherme Muzy,William N. Malatestinic, Anastasia Lampropoulou,Meghan Feely,Sophia Kyoungah See,Can Mert,Andrew Blauvelt

Dermatology and Therapy（2024）

引用 0|浏览6

暂无评分

摘要

The National Psoriasis Foundation (NPF) recommends evaluating patient response to treatment at week 12, with a target response of ≤ 1

查看译文

关键词

Biologics,Body surface area,Head-to-head,Ixekizumab,National Psoriasis Foundation,Plaque psoriasis,Real world,Systemic therapies,Treat-to-target,Treatment goals

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要